Comprehensive psychiatric assessment is the starting point. This includes clinical interview, validated rating scales (Vanderbilt for children, ASRS for adults), and where possible information from teachers, partners, or parents. We rule out conditions that mimic ADHD, identify common comorbidities, and form a clear diagnostic picture before treatment planning.

Stimulant medication (methylphenidate or dexamfetamine) is the most evidence-supported treatment for ADHD across all age groups, with response rates above 70 percent when correctly dosed. Non-stimulant options (atomoxetine, guanfacine) suit people who do not tolerate stimulants or have specific comorbidities. Medication decisions are individualised, reviewed regularly, and adjusted over time.

Behavioural and environmental strategies matter alongside medication, especially for children. Parent-management training, school accommodations (additional time, scaffolded assignments), structured routines, and ADHD-informed psychology all contribute. For adults, ADHD coaching, CBT adapted for ADHD, and workplace adjustments improve outcomes when combined with medication.

Diagnosis matters because ADHD overlaps with several other conditions. Anxiety, autism, learning disorders, sleep apnoea, trauma, and mood disorders can all look like ADHD or co-occur with it. A psychiatric assessment teases these threads apart so the treatment plan addresses the right targets in the right order.

Telehealth works well for ADHD assessment and ongoing review. We coordinate teacher rating forms by secure link, conduct comprehensive interviews via video, and provide detailed reports to your GP within 5 business days. For children, having the assessment from home reduces the additional stress of an unfamiliar clinic environment.

Stimulant prescribing in Australia is regulated by state-based authorities and requires a psychiatrist or paediatrician. We hold the relevant authorities and manage prescribing, monitoring (heart rate, blood pressure, growth, sleep), and dose adjustment over time. Where ongoing prescribing is being shared with a GP, we provide a clear handover plan.